Lonza will "soon" start production at two more Swiss manufacturing lines for Moderna's COVID-19 vaccine, CEO Pierre-Alain Ruffieux said, after the first line began production and is due to deliver a first batch this month.
"We expect that within a couple of months, we will reach cruising speed," Ruffieux told reporters on a conference call on Wednesday, without giving a firm timeline for when all three new production lines supplying Moderna will be at their full capacity and making ingredients for roughly 300 million vaccine doses annually.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.